July 12, 2004 Dr. Ram SasisekharanConsulting Agreement • November 12th, 2004 • Momenta Pharmaceuticals Inc • Biological products, (no disgnostic substances)
July 2, 2004 Dr. Robert S. Langer, Jr.Consulting Agreement • November 12th, 2004 • Momenta Pharmaceuticals Inc • Biological products, (no disgnostic substances)
Momenta Pharmaceuticals, Inc. Cambridge, Massachusetts 02142Development and Production Agreement • November 12th, 2004 • Momenta Pharmaceuticals Inc • Biological products, (no disgnostic substances)
Reference is made to the Development and Production Agreement for Active Pharmaceutical Ingredient between Siegfried (USA), Inc. and Siegfried Ltd. (“SIEGFRIED”) and Momenta Pharmaceuticals, Inc. (“MOMENTA”) dated October 10, 2003, as amended by Letter Agreements dated February 14, 2004 and May 17, 2004 (the “Agreement”). Capitalized terms used herein and not otherwise defined shall have the meanings given such terms in the Agreement.
EXTENSION OF LEASELease Extension Agreement • November 12th, 2004 • Momenta Pharmaceuticals Inc • Biological products, (no disgnostic substances)
It is agreed between Momenta Pharmaceuticals, Inc., LESSEE, and 68 Moulton Street Realty Trust, LESSOR, that the lease for four thousand, three hundred and sixteen (4,316) square feet of office space located on the second floor of 68 Moulton Street, Cambridge, MA 02138, and dated February 11, 2004 be extended for a period of four (4) months commencing September 1, 2004 and ending December 31, 2004.
AMENDMENTConsulting Agreement • November 12th, 2004 • Momenta Pharmaceuticals Inc • Biological products, (no disgnostic substances)
This Amendment modifies the Consulting Agreement between Peter Barton Hutt, Esq., (“Consultant”) and Momenta Pharmaceuticals, Inc. (“Company”) dated September 18, 2002, as amended by Letter Agreement dated September 29, 2003 (the “Agreement”). Capitalized terms used herein and not otherwise defined shall have the meanings given such terms in the Agreement. Consultant and Company hereby agree as follows:
INDUSTRY CONSULTING AGREEMENTConsulting Agreement • November 12th, 2004 • Momenta Pharmaceuticals Inc • Biological products, (no disgnostic substances)
THIS AGREEMENT is made and entered into by and between MOMENTA PHARMACEUTICALS, INC., a Delaware corporation, having a place of business at 675 West Kendall Street, Cambridge, Massachusetts 02142 (“Company”) and Bennett M. Shapiro (“Consultant”) and shall be effective upon the date it is fully executed by both parties (the “Effective Date”).
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. SUBLEASE AGREEMENT BY AND BETWEEN VERTEX PHARMACEUTICALS INCORPORATED as Sublandlord AND MOMENTA PHARMACEUTICALS, INC. as...Sublease Agreement • November 12th, 2004 • Momenta Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Massachusetts
Subtenant’s Share: The ratio, expressed as a percentage, of the Rentable Square Footage of the premises leased by Subtenant to the Rentable Square Footage of the Master Premises, equal to 6.88% from the Commencement Date until the day prior to the Sublease Premises Rent Commencement Date and 15.48% thereafter, subject to adjustment based on remeasurement pursuant to Section 1(l).
EXTENSION OF LEASELease Extension • November 12th, 2004 • Momenta Pharmaceuticals Inc • Biological products, (no disgnostic substances)
It is agreed between Momenta Pharmaceuticals, Inc., LESSEE, and 68 Moulton Street Realty Trust, LESSOR, that the lease for four thousand, three hundred and sixteen (4,316) square feet of office space located on the third floor of 68 Moulton Street, Cambridge, MA 02138, and dated October 16, 2003 be extended for a period of four (4) months commencing September 1, 2004 and ending December 31, 2004.
